Laboratory Historical Financial Ratios
LH Stock | USD 207.94 0.03 0.01% |
Laboratory is lately reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 68.45, Book Value Per Share of 94.93 or Free Cash Flow Yield of 0.0592 will help investors to properly organize and evaluate Laboratory financial condition quickly.
Laboratory |
About Laboratory Financial Ratios Analysis
LaboratoryFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Laboratory investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Laboratory financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Laboratory history.
Laboratory Financial Ratios Chart
Laboratory of financial ratios usually calculated using numerical values taken directly from Laboratory financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Laboratory. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
As of now, Laboratory's Free Cash Flow Yield is decreasing as compared to previous years. The Laboratory's current Invested Capital is estimated to increase to 1.29, while Price To Sales Ratio is projected to decrease to 1.60. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Laboratory stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Laboratory sales, a figure that is much harder to manipulate than other Laboratory of multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Laboratory of dividend as a percentage of Laboratory stock price. Laboratory dividend yield is a measure of Laboratory stock productivity, which can be interpreted as interest rate earned on an Laboratory investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from Laboratory's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. As of now, Laboratory's Free Cash Flow Yield is decreasing as compared to previous years. The Laboratory's current Invested Capital is estimated to increase to 1.29, while Price To Sales Ratio is projected to decrease to 1.60.
2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0383 | 0.0106 | 0.0128 | 0.0122 | Price To Sales Ratio | 1.62 | 1.24 | 1.63 | 1.6 |
Laboratory fundamentals Correlations
Click cells to compare fundamentals
Laboratory Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Laboratory fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Ptb Ratio | 1.88 | 1.82 | 2.54 | 1.83 | 2.51 | 3.27 | |
Days Sales Outstanding | 63.98 | 78.77 | 67.43 | 74.03 | 62.99 | 68.45 | |
Book Value Per Share | 77.29 | 96.19 | 106.23 | 110.83 | 90.41 | 94.93 | |
Free Cash Flow Yield | 0.0841 | 0.0734 | 0.1 | 0.08 | 0.0442 | 0.0592 | |
Invested Capital | 0.87 | 0.94 | 0.72 | 0.62 | 0.66 | 1.29 | |
Operating Cash Flow Per Share | 14.76 | 21.95 | 32.16 | 21.47 | 15.24 | 16.01 | |
Stock Based Compensation To Revenue | 0.00926 | 0.007991 | 0.009534 | 0.009686 | 0.0106 | 0.0184 | |
Pb Ratio | 1.88 | 1.82 | 2.54 | 1.83 | 2.51 | 3.27 | |
Free Cash Flow Per Share | 10.67 | 18.02 | 27.4 | 16.18 | 10.04 | 10.54 | |
Inventory Turnover | 33.93 | 21.33 | 26.15 | 22.29 | 19.0 | 31.72 | |
Net Income Per Share | 8.41 | 15.99 | 24.58 | 14.04 | 4.8 | 3.85 | |
Days Of Inventory On Hand | 10.76 | 17.11 | 13.96 | 16.37 | 19.21 | 10.42 | |
Payables Turnover | 13.13 | 14.13 | 16.89 | 11.22 | 10.9 | 16.65 | |
Capex To Revenue | (0.0346) | (0.0273) | (0.0286) | (0.0324) | (0.0373) | (0.0392) | |
Cash Per Share | 3.54 | 13.57 | 15.34 | 4.72 | 6.16 | 6.47 | |
Pocfratio | 9.85 | 7.97 | 8.39 | 9.42 | 14.91 | 12.36 | |
Interest Coverage | 5.53 | 11.79 | 15.37 | 9.84 | 5.63 | 6.33 | |
Payout Ratio | 2.91 | 0.0975 | 0.42 | 0.15 | 0.61 | 0.64 | |
Pfcf Ratio | 13.62 | 9.7 | 9.85 | 12.5 | 22.65 | 23.78 | |
Days Payables Outstanding | 27.8 | 25.84 | 21.6 | 32.52 | 33.5 | 20.54 | |
Income Quality | 1.75 | 1.37 | 1.31 | 1.53 | 3.5 | 3.68 | |
Ev To Operating Cash Flow | 14.52 | 10.51 | 9.96 | 12.42 | 18.99 | 16.59 | |
Pe Ratio | 17.27 | 10.93 | 10.98 | 14.41 | 47.36 | 49.73 | |
Ev To Free Cash Flow | 20.08 | 12.8 | 11.69 | 16.48 | 28.85 | 30.29 | |
Earnings Yield | 0.0579 | 0.0915 | 0.0911 | 0.0694 | 0.0211 | 0.0345 | |
Net Debt To E B I T D A | 3.43 | 1.53 | 1.18 | 2.14 | 3.18 | 3.31 | |
Current Ratio | 1.13 | 1.66 | 1.92 | 1.5 | 1.17 | 1.76 | |
Tangible Book Value Per Share | (44.25) | (24.18) | (14.7) | (21.64) | (18.3) | (19.22) | |
Receivables Turnover | 5.71 | 4.63 | 5.41 | 4.93 | 5.79 | 4.98 | |
Graham Number | 120.97 | 186.05 | 242.41 | 187.12 | 98.81 | 103.75 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Laboratory Stock analysis
When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.46) | Dividend Share 2.88 | Earnings Share 4.33 | Revenue Per Share 139.628 | Quarterly Revenue Growth 0.035 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.